Phytochemical profile, toxicological evaluation of Rhipsalis baccifera (Sol.) Stearn (Cactaceae) extract and their antitumor activity in Ehrlich carcinoma-bearing mice
Authors:
- Jéssica Alves CavalcanteaJCJéssica Alves Cavalcantea
- Luiz da Silva Maia NetoLNLuiz da Silva Maia Neto
- Anna Lígia de Castro FigueiredoAFAnna Lígia de Castro Figueiredo
- Weslley Felix de OliveiraWOWeslley Felix de Oliveira
- José Roberto Pimentel Cabral de SeixasJSJosé Roberto Pimentel Cabral de Seixas
- Caio César da Silva GuedesCGCaio César da Silva Guedes
- Priscila Maria de Barros RodriguesPRPriscila Maria de Barros Rodrigues
- Vanessa Silva de AlmeidaVAVanessa Silva de Almeida
- Lucíola Abílio Dm de Medeiros RolimLRLucíola Abílio Dm de Medeiros Rolim
- Andrezo Adenilton SantosASAndrezo Adenilton Santos
- Joicy Kelly Alves da SilvaJSJoicy Kelly Alves da Silva
- Rômulo Carlos Dantas da CruzRCRômulo Carlos Dantas da Cruz
Open Access
- 5 October 2021
- journal article
- research article
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 1 (2) , 63-77
Abstract
Rhipsalis baccifera (Sol.) Stearn is a typical cactus from tropical regions with wide geographic distribution, and its therapeutic potential is not yet fully understood, such as antitumoral property. Thus, this study evaluated the cytotoxic ethanolic extract of R. baccifera (EERB) and its antitumor activity against Erlich's tumor in mice. The EERB was obtained, and its phytochemical profile was filed by thin-layer chromatography. The toxicity was evaluated in vitro and in vivo using the microcrustacean Artemia salina Leach and mice. The lethal dose was determined after implantation of a tumor cell suspension, with subsequent treatment with EERB (200 mg/kg and 100 mg/kg) 48h after implantation. These values represent the tenth part of the DL50 and CL50, respectively. The presence of phenols, tannins and triterpenes were demonstrated in the phytochemical results. Toxicity was dose-dependent, and the tumor inhibition was 84.1% and 75.8% at doses of 200 mg/kg and 100 mg/kg, respectively. We can highlight that the growth of Erlich's carcinoma suffered inhibitory effects against the EERB. EERB was found to have low acute toxicity and a high potential for use in antitumor therapy. Thus, new studies involving pre-clinical and clinical analyses of the extract are essential to determine the safe dose.Keywords
This publication has 50 references indexed in Scilit:
- Beneficial health effects of lupeol triterpene: A review of preclinical studiesLife Sciences, 2011
- Chemical analysis and antioxidant activities in vitro of polysaccharide extracted from Opuntia ficus indica Mill. cultivated in ChinaCarbohydrate Polymers, 2010
- Acute oral toxicity ofPereskia bleoandPereskia grandifoliain micePharmacognosy Magazine, 2010
- Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpeneCancer Letters, 2009
- Bioactive Constituents of the Stem Bark of Mitrephora glabraJournal of Natural Products, 2009
- Antineoplastic Agents. 454. Synthesis of the Strong Cancer Cell Growth Inhibitors trans-Dihydronarciclasine and 7-Deoxy-trans-dihydronarciclasineJournal of Natural Products, 2009
- Cytotoxic Components of Pereskia bleo (Kunth) DC. (Cactaceae) LeavesMolecules, 2009
- Nutritional and medicinal use of Cactus pear (Opuntia spp.) cladodes and fruitsFrontiers in Bioscience-Landmark, 2006
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Aderência e atividade microbicida de monócitos em portadores de esquistossomose mansônica na forma hepatoesplênica cirúrgicaActa Cirurgica Brasileira, 2003